These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


233 related items for PubMed ID: 20379108

  • 21. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
    Kantarjian H, Thomas D, O'Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ.
    Cancer; 2004 Dec 15; 101(12):2788-801. PubMed ID: 15481055
    [Abstract] [Full Text] [Related]

  • 22. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
    Horváth B, Demeter J, Eros N, Hársing J, Csomor J, Matolcsy A, Bottlik G, Gyori G, Marschalkó M, Kárpáti S.
    J Am Acad Dermatol; 2009 Nov 15; 61(5):885-8. PubMed ID: 19632742
    [Abstract] [Full Text] [Related]

  • 23. Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
    Wang M, Fayad L, Cabanillas F, Hagemeister F, McLaughlin P, Rodriguez MA, Kwak LW, Zhou Y, Kantarjian H, Romaguera J.
    Cancer; 2008 Nov 15; 113(10):2734-41. PubMed ID: 18973182
    [Abstract] [Full Text] [Related]

  • 24. [Long term remission following relapsed CNS lymphoma].
    Kura Y, Sawada U, Tsuboi I, Suzuki K, Yamazaki T, Satou Y, Horie T.
    Rinsho Ketsueki; 1995 Mar 15; 36(3):227-9. PubMed ID: 7540223
    [Abstract] [Full Text] [Related]

  • 25. [Beneficial effects of CHOP therapy in a case of intravascular large B-cell lymphoma diagnosed by skin biopsy].
    Munakata S, Hirano S, Yoshiyama Y, Koizumi M, Kobayasi T, Hattori T.
    Rinsho Shinkeigaku; 2000 May 15; 40(5):476-9. PubMed ID: 11002731
    [Abstract] [Full Text] [Related]

  • 26. [A case of intravascular large B-cell lymphoma associated with transverse myelopathy].
    Seki M, Sugawara T, Yamamoto K, Takahashi T, Harigae H.
    Gan To Kagaku Ryoho; 2011 Nov 15; 38(11):1885-8. PubMed ID: 22083204
    [Abstract] [Full Text] [Related]

  • 27. [Sustained complete remission of intravascular large B-cell lymphoma with recurrent CNS involvement by autologous peripheral blood stem cell transplantation preconditioned with TBC regimen].
    Miura Y, Toyooka N, Iwai F, Matsui Y, Hirai M, Kaneko H, Watanabe M, Tsudo M.
    Rinsho Ketsueki; 2011 Dec 15; 52(12):1876-81. PubMed ID: 22241155
    [Abstract] [Full Text] [Related]

  • 28. Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.
    Tey SK, Marlton PV, Hawley CM, Norris D, Gill DS.
    Am J Hematol; 2008 Apr 15; 83(4):330-3. PubMed ID: 17876769
    [Abstract] [Full Text] [Related]

  • 29. Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.
    Khouri IF, Romaguera J, Kantarjian H, Palmer JL, Pugh WC, Korbling M, Hagemeister F, Samuels B, Rodriguez A, Giralt S, Younes A, Przepiorka D, Claxton D, Cabanillas F, Champlin R.
    J Clin Oncol; 1998 Dec 15; 16(12):3803-9. PubMed ID: 9850025
    [Abstract] [Full Text] [Related]

  • 30. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T, Tóth E, Molnár Z, Várady E, Deák B, Horváth A, Horváth GI, Eid H, Schneider K, Lovey J, Keresztes S, Esik O, Lengyel Z, Rosta A.
    Orv Hetil; 2004 Dec 12; 145(50):2531-7. PubMed ID: 15662753
    [Abstract] [Full Text] [Related]

  • 31. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
    Kanaji N, Ishibashi K, Uno H, Hino N.
    Gan To Kagaku Ryoho; 2002 Dec 12; 29(13):2569-72. PubMed ID: 12506485
    [Abstract] [Full Text] [Related]

  • 32. Testicular lymphoma, intraocular (vitreoretinal) lymphoma, and brain lymphoma: involvement of three immunoprivileged sites in one patient.
    Pe'er J, Rowe JM, Frenkel S, Dann EJ.
    Am J Hematol; 2010 Aug 12; 85(8):631-3. PubMed ID: 20658596
    [No Abstract] [Full Text] [Related]

  • 33. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].
    Lin TY, Zhang HY, Huang Y, Guan ZZ, Shen T, Shi YK, Zhu J, Ke XY, Wang HQ, Shen ZX, Yu SY, Liu T, Shi XL.
    Ai Zheng; 2005 Dec 12; 24(12):1421-6. PubMed ID: 16351785
    [Abstract] [Full Text] [Related]

  • 34. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD, Wolff SN, Stein RS, Greer JP, Cousar JB, Greco FA.
    Cancer Treat Rep; 1986 Aug 12; 70(8):953-8. PubMed ID: 3015406
    [Abstract] [Full Text] [Related]

  • 35. [Intravascular lymphomatosis: a case report].
    Adachi H, Tsuboi M, Hayashi K.
    No Shinkei Geka; 2001 Jul 12; 29(7):659-65. PubMed ID: 11517508
    [Abstract] [Full Text] [Related]

  • 36. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
    Iguchi T, Miyazawa K, Okabe S, Kawakubo K, Shimamoto T, Kuriyama Y, Ito Y, Kimura Y, Ohyashiki K, Serizawa H, Iwaya K, Mukai K.
    Rinsho Ketsueki; 2004 Oct 12; 45(10):1129-34. PubMed ID: 15553050
    [Abstract] [Full Text] [Related]

  • 37. [Primary diffuse large B-cell lymphoma of the bone marrow complicated with autoimmune hemolytic anemia and erythroid hypoplasia].
    Sumi M, Ichikawa N, Shimizu I, Yotsumoto M, Ueno M, Kobayashi H.
    Rinsho Ketsueki; 2007 Jul 12; 48(7):571-5. PubMed ID: 17695307
    [Abstract] [Full Text] [Related]

  • 38. Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial.
    Laver JH, Kraveka JM, Hutchison RE, Chang M, Kepner J, Schwenn M, Tarbell N, Desai S, Weitzman S, Weinstein HJ, Murphy SB.
    J Clin Oncol; 2005 Jan 20; 23(3):541-7. PubMed ID: 15659500
    [Abstract] [Full Text] [Related]

  • 39. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.
    Kantarjian HM, O'Brien S, Smith TL, Cortes J, Giles FJ, Beran M, Pierce S, Huh Y, Andreeff M, Koller C, Ha CS, Keating MJ, Murphy S, Freireich EJ.
    J Clin Oncol; 2000 Feb 20; 18(3):547-61. PubMed ID: 10653870
    [Abstract] [Full Text] [Related]

  • 40. Prostate involvement by intravascular large B-cell lymphoma: a case report with literature review.
    Xu M, Yang Q, Li M, Geng W, Huang W, Chen Y.
    Int J Surg Pathol; 2011 Aug 20; 19(4):544-7. PubMed ID: 21632638
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.